Nanotechnology-medicated therapeutic HPV DNA vaccines (2018)
Despite the efficacy of prophylactic vaccines, it will take decades to achieve the full impact on reducing the incidence of
human papillomavirus (HPV)-associated cancers. Thus, development of therapeutic HPV vaccines is crucial to cure
patients with established HPV infections. DNA vaccines are a desired option but their potency is limited. This project
aims to develop a novel HPV DNA vaccine nano-platform with improved efficacy, providing next generation of potent
therapeutic HPV DNA vaccines.